13F-HR filed by Lion Point Capital, LP
Lion Point Capital, LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 32 holding rows worth $178,951,319.
- Accession
- 0001013594-24-000479
- Filer
- CIK 1643354
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 32 entries on the cover page, a total value of $178,951,319 stated on the cover page (in dollars after the unit check, H1), rows summing to $178,951,319 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SEMTECH CORP COM | 816850101 | Stock | 2,500,000 | $68,725,000 | dollars as filed | call |
| iShares Russell 2000 ETF | 464287655 | SHS | 247,500 | $52,049,250 | dollars as filed | put |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 2,119,136 | $19,156,989 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 1,046,667 | $7,640,669 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 50,000 | $4,744,500 | dollars as filed | put |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,300,207 | $4,117,371 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 130,691 | $2,578,533 | dollars as filed | |
| GERON CORP | 374163103 | COM | 600,000 | $1,980,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 70,335 | $1,908,189 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 170,000 | $1,890,400 | dollars as filed | |
| BURGERFI INTERNATIONAL INC | 12122L101 | COM | 2,745,938 | $1,585,779 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 65,000 | $1,547,000 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 82,500 | $1,393,425 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 45,000 | $1,130,400 | dollars as filed | put |
| BLUEBIRD BIO INC | 09609G100 | COM | 848,256 | $1,085,768 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 7,500 | $1,034,400 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 32,000 | $939,520 | dollars as filed | |
| ENPHYS ACQUISITION CORP | G3167L109 | CL A ORD SHS | 78,125 | $845,313 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 60,000 | $774,600 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 235,000 | $730,850 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 32,500 | $684,775 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 1,000,000 | $629,500 | dollars as filed | principal |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 78,000 | $601,380 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 42,500 | $347,225 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 340,761 | $263,783 | dollars as filed | |
| LUMOS PHARMA INC | 55028X109 | COM | 90,794 | $256,039 | dollars as filed | |
| BATTALION OIL CORP | 07134L107 | COM | 19,926 | $112,781 | dollars as filed | |
| BURGERFI INTERNATIONAL INC | 12122L119 | *W EXP 12/16/202 | 2,083,438 | $81,254 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 75,000 | $58,943 | dollars as filed | |
| Microsoft Corp | 594918104 | COM | 100 | $42,072 | dollars as filed | |
| Alphabet Inc. Reg. Shares C | 02079K107 | COM | 100 | $15,226 | dollars as filed | |
| SEMTECH CORP COM | 816850101 | Stock | 14 | $385 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-24-000479 | this filing | 2024-05-15 | acceptance time not in the bulk data set |